3,5-dimethyl-4-<<5-(3-methyl-5-isoxazolyl)pentyl>oxy>benzaldehyde | 124811-90-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3,5-dimethyl-4-<<5-(3-methyl-5-isoxazolyl)pentyl>oxy>benzaldehyde
• 英文别名: 3,5-Dimethyl-4-[5-(3-methyl-5-isoxazolyl)pentyloxy]benzaldehyde；3,5-dimethyl-4-[5-(3-methyl-1,2-oxazol-5-yl)pentoxy]benzaldehyde
• CAS: 124811-90-1
• 化学式: C₁₈H₂₃NO₃
• 分子量: 301.386
• InChiKey: RCDNBLMTMSLMRT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  22
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  52.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3,5-dimethyl-4-<<5-(3-methyl-5-isoxazolyl)pentyl>oxy>benzaldehyde 在 sodium azide 、 盐酸羟胺 、 乙酸酐 、 potassium carbonate 、 氯化铵 作用下， 以 吡啶 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 86.0h， 生成 5-{5-[2,6-dimethyl-4-(2-methoxycarbonylmethyl-2H-tetrazol-5-yl)phenoxy]pentyl}-3-methylisoxazole
  参考文献：
  名称：

  Antipicornavirus activity of tetrazole analogs related to disoxaril

  摘要：

  A series of tetrazole analogues of Win 54954, a broad-spectrum antipicornavirus compound, has been synthesized to address the acid lability of the oxazoline ring of this series of compounds. The results of X-ray crystallography studies of several members of the oxazoline series bound to human rhinovirus type IA and 14 have been used to design compounds in the tetrazole series with a broad spectrum of activity. Compound 16b, which has a three-carbon linkage between the isoxazole and phenyl rings and a propyl chain extending from the isoxazole ring, exhibiting an MIC80 for 15 rhinovirus serotypes of 0.20 muM as compared to 0.40 muM for Win 54954. X-ray studies of 16b bound to human rhinovirus-14 show that the propyl side chain extends into a pore in the binding site with the possibility of hydrophobic interactions with a pocket formed by Leu106 and a portion of Ser107.

  DOI：

  10.1021/jm00074a004
• 作为产物：
  描述：

  3,5-二甲基-4-羟基苯甲醛 、 5-(5-溴戊基)-3-甲基异恶唑 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 5.0h， 以82%的产率得到3,5-dimethyl-4-<<5-(3-methyl-5-isoxazolyl)pentyl>oxy>benzaldehyde
  参考文献：
  名称：

  Antipicornavirus activity of tetrazole analogs related to disoxaril

  摘要：

  A series of tetrazole analogues of Win 54954, a broad-spectrum antipicornavirus compound, has been synthesized to address the acid lability of the oxazoline ring of this series of compounds. The results of X-ray crystallography studies of several members of the oxazoline series bound to human rhinovirus type IA and 14 have been used to design compounds in the tetrazole series with a broad spectrum of activity. Compound 16b, which has a three-carbon linkage between the isoxazole and phenyl rings and a propyl chain extending from the isoxazole ring, exhibiting an MIC80 for 15 rhinovirus serotypes of 0.20 muM as compared to 0.40 muM for Win 54954. X-ray studies of 16b bound to human rhinovirus-14 show that the propyl side chain extends into a pore in the binding site with the possibility of hydrophobic interactions with a pocket formed by Leu106 and a portion of Ser107.

  DOI：

  10.1021/jm00074a004

文献信息

• Haloalkoxy phenyl 4,5 dihydro oxazoles
  申请人：Sterling Drug Inc.

  公开号：US04939267A1

  公开（公告）日：1990-07-03

  Compounds of the formulas: ##STR1## wherein Het is an oxazole or oxazine moiety; X is O, S or SO, n is an integer from 3 to 9, Y is an aliphatic bridge; and the various R groups represent hydrogen or various substituents as described herein, are useful as antiviral agents, especially against picornaviruses. N-(Chloroalkyl)amide intermediates for the compounds of Formula I are also active as antiviral agents. Related compounds outside the scope of the above formulas are also disclosed.

  上述公式中，化合物的公式为：##STR1## 其中Het是噁唑或噁嗪基团；X为O，S或SO，n为3至9的整数，Y为脂肪桥；各种R基团表示氢或如本文所述的各种取代基，对于抗病毒剂特别是针对小肠病毒具有用处。公式I化合物的N-(氯烷基)酰胺中间体也具有抗病毒活性。还公开了范围外的相关化合物。
• N-haloalkyl-4-(isoxazol-5-yl)alkoxy benzamides
  申请人：Sterling Drug, Inc.

  公开号：US05002960A1

  公开（公告）日：1991-03-26

  Compounds of the formulas: ##STR1## wherein Het is an oxazole or oxazine moiety; X is O, S or SO, n is an integer from 3 to 9, Y is an aliphatic bridge; and the various R groups represent hydrogen or various substituents as described herein, are useful as antiviral agents, especially against picornaviruses. N-(Chloroalkyl)amide intermediates for the compounds of Formula I are also active as antiviral agents. Related compounds outside the scope of the above formulas are also disclosed. Also disclosed are novel intermediates, N-halo-alkyl-4-(isoxazol-5-yl)alkoxybenzamides, also useful as antiviral agents.

  分子式为##STR1##的化合物，在其中Het是噁唑或噁唑烷基；X是O，S或SO，n是从3到9的整数，Y是脂肪桥；各种R基代表氢或如下所述的各种取代基，对于抗病毒剂，特别是对于小肠病毒具有用处。Formula I化合物的N-(氯代烷基)酰胺中间体也是作为抗病毒剂活性的。还披露了范围外的相关化合物。还披露了新的中间体，N-卤代烷基-4-(异噁唑-5-基)烷氧基苯甲酰胺，也可作为抗病毒剂使用。
• Di-heterocyclic compounds and their use as antiviral agents
  申请人：Sterling Drug Inc.

  公开号：US04843087A1

  公开（公告）日：1989-06-27

  Compounds of the formulas: ##STR1## wherein Het is an oxazole or oxazine moiety; X is O, S or SO, n is an integer from 3 to 9, Y is an aliphatic bridge; and the various R groups represent hydrogen or various substituents as described herein, are useful as antiviral agents, especially against picornaviruses. N-(Chloroalkyl)amide intermediates for the compounds of Formula I are also active as antiviral agents. Related compounds outside the scope of the above formulas are also disclosed.

  公式为：##STR1## 其中Het为噁唑或噁唑烷基团；X为O，S或SO，n为3到9的整数，Y为脂肪桥；各种R基代表氢或如此处所述的各种取代基，可用作抗病毒剂，特别是对抗小肠病毒。公式I化合物的N-(氯烷基)酰胺中间体也是抗病毒剂。还揭示了范围外的相关化合物。
• US4843087A
  申请人：——

  公开号：US4843087A

  公开（公告）日：1989-06-27
• US4939267A
  申请人：——

  公开号：US4939267A

  公开（公告）日：1990-07-03